T
Tito Livraghi
Researcher at Harvard University
Publications - 60
Citations - 13534
Tito Livraghi is an academic researcher from Harvard University. The author has contributed to research in topics: Percutaneous ethanol injection & Hepatocellular carcinoma. The author has an hindex of 37, co-authored 60 publications receiving 13056 citations. Previous affiliations of Tito Livraghi include University of Bologna.
Papers
More filters
Journal ArticleDOI
Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria
S. Nahum Goldberg,Clement J. Grassi,John F. Cardella,J. William Charboneau,Gerald D. Dodd,Damian E. Dupuy,Debra A. Gervais,Alice Gillams,Robert A. Kane,Fred T. Lee,Tito Livraghi,John P. McGahan,David A. Phillips,Hyunchul Rhim,Stuart G. Silverman +14 more
TL;DR: It is the group's intention that adherence to the recommendations will facilitate achievement of the main objective: improved precision and communication in this field that lead to more accurate comparison of technologies and results and, ultimately, to improved patient outcomes.
Journal ArticleDOI
Treatment of Focal Liver Tumors with Percutaneous Radio-frequency Ablation: Complications Encountered in a Multicenter Study
Tito Livraghi,Luigi Solbiati,M. Franca Meloni,G. Scott Gazelle,Elkan F. Halpern,S. Nahum Goldberg +5 more
TL;DR: Radio-frequency ablation is a relatively low-risk procedure for the treatment of focal liver tumors and the number of complications was not significantly different when tumor size or electrode type were compared.
Journal ArticleDOI
Small Hepatocellular Carcinoma: Treatment with Radio-frequency Ablation versus Ethanol Injection
Tito Livraghi,S. Nahum Goldberg,Sergio Lazzaroni,Franca Meloni,Luigi Solbiati,G. Scott Gazelle +5 more
TL;DR: RF ablation results in a higher rate of complete necrosis and requires fewer treatment sessions than percutaneous ethanol injection, however, the complication rate is higher with RF ablation than with percutaneously ethanol injection.
Journal ArticleDOI
Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients.
Luigi Solbiati,Tito Livraghi,S N Goldberg,T. Ierace,Meloni F,M. Dellanoce,Luca Cova,Elkan F. Halpern,G S Gazelle +8 more
TL;DR: RF ablation is an effective method to treat hepatic metastases from colorectal carcinoma and Frequency and time to local recurrence were related to lesion size (P < or =.001).
Journal ArticleDOI
Hepatocellular Carcinoma: Radio-frequency Ablation of Medium and Large Lesions
Tito Livraghi,S. Nahum Goldberg,Sergio Lazzaroni,Franca Meloni,Tiziana Ierace,Luigi Solbiati,G. Scott Gazelle +6 more
TL;DR: RF ablation appears to be an effective, safe, and relatively simple procedure for the treatment of medium and large HCCs in patients with cirrhosis or chronic hepatitis.